Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DOTAREM
- Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas
- High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
- Collagen-targeted PET Imaging for Early Interstitial Lung Disease
- Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
- Dotarem vs Gadobutrol Contrast for Breast MRI
- Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
- Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
- Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
- Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
- Eovist vs. Dotarem Healthy Volunteer MRI
- DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years
- Evaluation of Gadoterate in Patients With Decreased Kidney Function
- Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
- Use of Gadolinium in CT Pulmonary Angiography
- A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography
- Crossover Comparison of MultiHance and Dotarem
- Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
- DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
- Safety and Dialysability of Dotarem® in Dialysed Patients
- Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
- Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
- Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
- Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
- Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
- Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
- Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
- Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
- Renal Safety Evaluation After Dotarem®-Enhanced MRI
Clinical trials list
click for details